Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Am J Gastroenterol. 2014 Sep 2;109(11):1757–1763. doi: 10.1038/ajg.2014.264

Figure 3.

Figure 3

Time from initial visit to death or transplant (Txp) showed a significant difference between covert hepatic encephalopathy (CHE) and no-CHE groups (P=0.006). The Kaplan–Meier curve for estimated cumulative incidence of the particular outcome in the Y axis and months from initial entry in the X axis. The red lines depict patients with CHE, and blue lines denote patients who were CHE negative at study entry, with each dot signifying censoring due to reaching an outcome. Log-rank statistics were used to compare groups.